Comparison
2p21 Microdeletion Syndrome C4304537 vs 14q32 Duplication Syndrome C4225449
Clinical comparison between 2p21 Microdeletion Syndrome and 14q32 Duplication Syndrome for differential diagnosis and treatment planning.
2p21 Microdeletion Syndrome C4304537
A rare genetic disorder involving deletion of genetic material on chromosome 2. It may affect multiple body systems and development. Management is tailored to individual symptoms.
14q32 Duplication Syndrome C4225449
A rare chromosomal disorder where extra genetic material from chromosome 14 is present. It can affect development and cause intellectual disability, distinctive facial features, and other health issues. Management focuses on addressing symptoms with specialized care.
6 comparison axes
Onset
2p21 Microdeletion Syndrome C4304537
0-null
14q32 Duplication Syndrome C4225449
0-0
Onset patterns differ
Severity
2p21 Microdeletion Syndrome C4304537
severe
14q32 Duplication Syndrome C4225449
moderate
Different severity levels
Chronic
2p21 Microdeletion Syndrome C4304537
Chronic
14q32 Duplication Syndrome C4225449
Chronic
Differing course
Communicable
2p21 Microdeletion Syndrome C4304537
No
14q32 Duplication Syndrome C4225449
No
Different transmission
Body System
2p21 Microdeletion Syndrome C4304537
congenital
14q32 Duplication Syndrome C4225449
congenital
Same/different system
Category
2p21 Microdeletion Syndrome C4304537
rare-disease
14q32 Duplication Syndrome C4225449
genetic
Different category
Bottom line
2p21-microdeletion-syndrome-C4304537 and 14q32-duplication-syndrome-C4225449 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p21 Microdeletion Syndrome C4304537 | 14q32 Duplication Syndrome C4225449 | Discriminating power |
|---|---|---|---|
| Chromosomal change | Loss of genetic material at chromosome 2p21. | Extra genetic material from chromosome 14q32. | High |
| Development | Development and multiple body systems may be affected; exact pattern is not established here. | Development may be affected, and intellectual disability can occur. | Moderate |
| Physical features | Specific facial or organ findings are not established by the supplied description. | Distinctive facial features and other health issues may occur. | Low |
When to favor each condition
Choose 2p21 Microdeletion Syndrome C4304537 when
Testing confirms a deletion at 2p21
The identified copy-number loss supports this diagnosis rather than symptoms alone.
High
Multisystem congenital concerns suggest chromosome 2 loss
This warrants targeted genetic confirmation; clinical suspicion alone is insufficient.
Moderate
Reported severity is marked
The source labels it severe, but individual effects remain variable.
Low
Choose 14q32 Duplication Syndrome C4225449 when
Testing confirms extra material at 14q32
A confirmed duplication distinguishes it from a 2p21 deletion.
High
Developmental disability with possible distinctive facial features
These findings fit the supplied description but still require genetic confirmation.
Moderate
Overall impact appears moderate
The source severity is moderate, although individual needs can differ.
Low
How key tests differ
| Test | 2p21 Microdeletion Syndrome C4304537 | 14q32 Duplication Syndrome C4225449 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss involving 2p21. | Copy-number gain involving 14q32. | A confirmed result distinguishes deletion from duplication; reporting should be interpreted by genetics specialists. |
| Karyotype | A small deletion may not be visible. | A small duplication may not be visible. | A normal karyotype does not exclude either condition. |
| Clinical genetics assessment | Findings are correlated with possible 2p21 effects. | Findings are correlated with possible 14q32 effects. | Clinical features alone cannot reliably separate the two diagnoses. |
Prognosis comparison
2p21 Microdeletion Syndrome C4304537
- Outcome
- A chronic course is described, with severe severity in the source, but individual outcomes are not established.
- Factors
- Affected systems, developmental needs, and available supportive care.
14q32 Duplication Syndrome C4225449
- Outcome
- A chronic course is described, with moderate source severity; outcomes vary and are not definitively established.
- Factors
- Degree of developmental impact, associated health issues, and access to specialized care.
Time frame: Often lifelong, although the supplied data do not define milestones or survival.
Exact genetic result, clinical findings, comorbidities, and individualized support.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental difficulty | Possible, but its extent is not established here. Intellectual disability may occur. Neither description defines severity for every person. |
| Other health issues | Multiple body systems may be involved. Additional health issues may accompany developmental findings. Specific complications should not be assumed without individual evaluation. |
| Support needs | Care is tailored to identified symptoms. Management focuses on symptoms and specialized care. Support needs may change over time. |
Patient education highlights
- HighDiagnosis
A chromosomal test result is not the same as predicting every symptom; a clinician should explain its meaning.
- HighCare
Management is individualized and symptom-focused for both conditions.
- MediumFamily planning
Relatives may be offered genetic counseling; recurrence implications depend on the specific test result.